Johnson & Johnson Hike 2021 Profit Forecast as COVID-19 Vaccine Sales Grow

Sales of the cancer treatment Darzalex helped Johnson &Johnson deliver better-than-expected third-quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol. The world’s biggest maker of health care products hiked its 2021 earnings forecast after saying Tuesday that net income climbed 3% to $3.67 billion in the recently completed quarter. Sales of the company’s single-shot COVID-19 vaccine started to pick up in the quarter and nearly doubled what it brought in during the first half of 2021. J&J also said that sales of over-the-counter drugs, which do not need prescriptions, grew 18% globally as more customers bought Tylenol and Motrin partly because they wanted vaccine symptom relief. [time-brightcove not-tgx=”true”] Injections of COVID-19 vaccines, which have been widely available since spring, can come with side effects like arm soreness or a temporary fever. J&J rang up $502 million in sales from its COVID-19 vaccine in the third quarter after pulling in $264 million during the first half of 2021. The New Brunswick, New Jersey, company’s vaccine started slow earlier this year. Its rollout was hurt by manufacturing complications and concern about rare side effects, including a blood clot disorder. But company leaders expect sales to pick up and total around $2.5 billion for the year. The company has said it doesn’t intend to profit from the shots. Last Friday, Food and Drug Administration advis...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized biztech2030 Vaccines wire Source Type: news

Related Links:

Former US Secretary of State Colin Powell died on Monday of Covid-19 complications. His family announced that he was fully vaccinated. He was 84 years old, and had multiple myeloma, a blood cancer.
Source: - Health - Category: Consumer Health News Source Type: news
New Brunswick, N.J. (October 19, 2021) – Johnson &Johnson (NYSE: JNJ) today announced results for third-quarter 2021. “Our third-quarter results demonstrate solid performance across Johnson &Johnson, driven by robust above-market results in Pharmaceuticals, ongoing recovery in Medical Devices, and strong growth in Consumer Health,” said Alex Gorsky, Chairman and Chief Executive Officer. “In the face of evolving marketplace dynamics resulting from the effects of COVID-19 and other global trends, we have continued to demonstrate the responsiveness and agility required to meet the needs of our ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Financial Source Type: news
Deaths among people who have been fully vaccinated remain rare, but older adults and those with compromised immune systems are at much higher risk.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Disease Rates Coronavirus (2019-nCoV) Vaccination and Immunization Cancer Multiple Myeloma Immune System Antibodies Multiple Myeloma Research Foundation Powell, Colin L your-feed-health Source Type: news
Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response...(PRWeb October 19, 2021)Read the full story at
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
Doctors say Colin Powell's age, his battle with multiple myeloma - a type of blood cancer - and Parkinson's contributed to his heightened risk of death from Covid despite being fully vaccinated.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Colin Powell had a form of blood cancer that saps natural immunity and also undermines the effects of vaccines like the ones used against Covid-19.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Multiple Myeloma Bone Marrow Deaths (Fatalities) Immune System Blood Powell, Colin L Source Type: news
The death of Colin Powell, an 84-year-old former four-star general who served as Chairman of the Joint Chiefs of Staff under U.S. President George H.W. Bush and Secretary of State under President George W. Bush and is perhaps best known for his role in bringing the U.S. into its second war in Iraq, is a high-profile reminder of a grim reality: COVID-19 is not just a pandemic of the unvaccinated, as current president Joe Biden likes to say, but a pandemic of the elderly, too. From early on in the pandemic, we’ve known the virus disproportionately kills older people, and the overall data make that pretty clear: About 5...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Blood Cancer Journal, Published online: 02 August 2021; doi:10.1038/s41408-021-00530-3The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment
Source: Blood Cancer Journal - Category: Hematology Authors: Source Type: research
Conditions:   COVID-19 Infection;   Hematopoietic and Lymphoid System Neoplasm;   Leukemia;   Lymphoma;   Plasma Cell Myeloma Interventions:   Biological: COVID-19 Vaccine;   Other: Diagnostic Laboratory Biomarker Analysis;   Biological: Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting
Source: - Category: Research Source Type: clinical trials
New Brunswick, N.J. (July 21, 2021) – Johnson &Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson &Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to patients and consumers around the world, in addition to advancing our pipeline with new product launches and regulatory...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Centers for Disease Control and Prevention (CDC) | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Health | Health Management | Hospitals | Ibuprofen | Medical Devices | Myeloma | Pfizer | Profits and Losses | Vaccines